| 18 years and more
- | Country :
- France
- | organs :
- Métastases hépatiques
- Côlon ou Rectum (colorectal)
- | Specialty :
- Thérapies Ciblées
- Chimiothérapie
Extract
A randomized, open-label, controlled, multi-center phase II study to evaluate the efficacy and safety of adecatumumab alone or sequentially to folfox relative to folfox after R0 resection of colorectal liver metastases.
Scientific Abstract
en cours d'intégration;